Case Report

Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven)

Table 3

Coagulating factor evaluation during bleeding and treatment.

DatePT patientPT controlPT activityINRPTT

One day before bleeding1212100131
First day of bleeding1212100130
Second day of bleeding13.8121.328
Third day of bleeding1212129